These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25046399)

  • 1. Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.
    Salem Fourati I; Grenier AJ; Jolette É; Merindol N; Ovetchkine P; Soudeyns H
    J Vis Exp; 2014 Jul; (89):. PubMed ID: 25046399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
    Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
    J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.
    Smith JG; Levin M; Vessey R; Chan IS; Hayward AR; Liu X; Kaufhold RM; Clair J; Chalikonda I; Chan C; Bernard M; Wang WW; Keller P; Caulfield MJ
    J Med Virol; 2003; 70 Suppl 1():S38-41. PubMed ID: 12627485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.
    Otani N; Baba K; Okuno T
    J Immunol Methods; 2009 Dec; 351(1-2):71-4. PubMed ID: 19818791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
    J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
    Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
    Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
    Sadaoka K; Okamoto S; Gomi Y; Tanimoto T; Ishikawa T; Yoshikawa T; Asano Y; Yamanishi K; Mori Y
    J Infect Dis; 2008 Nov; 198(9):1327-33. PubMed ID: 18774884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
    Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
    J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple-to-Perform
    Boccard M; Conrad A; Mouton W; Valour F; Roure-Sobas C; Frobert E; Rohmer B; Alcazer V; Labussière-Wallet H; Ghesquières H; Venet F; Brengel-Pesce K; Trouillet-Assant S; Ader F
    Front Immunol; 2022; 13():919806. PubMed ID: 35967359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.
    Rabalais GP; Berkowitz FE; Hayward AR; Levin MJ
    Clin Exp Immunol; 1989 Mar; 75(3):381-6. PubMed ID: 2539281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
    Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
    Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus.
    Jenkins DE; Redman RL; Lam EM; Liu C; Lin I; Arvin AM
    J Infect Dis; 1998 Oct; 178(4):940-8. PubMed ID: 9806019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.
    Lenders K; Ogunjimi B; Beutels P; Hens N; Van Damme P; Berneman ZN; Van Tendeloo VF; Smits EL
    J Immunol Methods; 2010 May; 357(1-2):51-4. PubMed ID: 20214906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.